Novo Nordisk Partners with OpenAI to Accelerate Drug Development Using AI

Gate News message, April 16 — Novo Nordisk, the world’s leading manufacturer of diabetes and obesity treatment medications, announced on April 14 a strategic partnership with OpenAI to accelerate drug development and integrate AI across manufacturing, supply chain, and corporate operations.

The collaboration focuses on analyzing complex datasets to identify promising drug candidates and shortening the timeline from pre-clinical stages to market launch. OpenAI’s latest AI models will be applied to strengthen Novo Nordisk’s next-generation drug pipeline, including treatments like Ozempic and Wegovy. OpenAI will also provide employee training programs to enhance AI capabilities across the organization. Pilot programs will begin in research and development, manufacturing, and commercial operations, with full company-wide integration planned by end of 2026. The financial terms were not disclosed.

Novo Nordisk CEO Mike Doustdar emphasized the partnership aims at human augmentation rather than workforce reduction. The collaboration reflects accelerating partnerships between Big Pharma and Big Tech, with companies like Eli Lilly and AstraZeneca also strengthening ties with AI firms. Experts anticipate Novo Nordisk’s extensive clinical data combined with OpenAI’s large language models could expand research beyond obesity and diabetes to cardiovascular and rare diseases, potentially revolutionizing the pharmaceutical industry’s innovation pace.

Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.

Related Articles

DeepSeek Slashes Input Cache Prices to 1/10 of Launch Price; V4-Pro Drops to 0.025 Yuan per Million Tokens

Gate News message, April 26 — DeepSeek has reduced input cache prices across its entire model lineup to one-tenth of launch prices, effective immediately. The V4-Pro model is available at a limited-time 2.5x discount, with the promotion running through May 5, 2026, 11:59 PM UTC+8. Following both re

GateNews5h ago

OpenAI Recruits Top Enterprise Software Talent as Frontier Agents Disrupt Industry

Gate News message, April 26 — OpenAI and Anthropic have been recruiting senior executives and specialized engineers from major enterprise software companies including Salesforce, Snowflake, Datadog, and Palantir. Denise Dresser, former CEO of Slack under Salesforce, joined OpenAI as chief revenue of

GateNews5h ago

Baidu Qianfan Launches Day 0 Support for DeepSeek-V4 with API Services

Gate News message, April 25 — DeepSeek-V4 preview version went live and open-sourced on April 25, with Baidu Qianfan platform under Baidu Intelligent Cloud providing Day 0 API service adaptation. The model features a million-token extended context window and is available in two versions: DeepSeek-V4

GateNews11h ago

Stanford AI course combined with industry leaders Huang Renxun and Altman, challenging to create value for the world in just ten weeks!

The AI computer science course 《Frontier Systems》 recently launched by Stanford University has attracted intense attention from the industry-university collaboration community, drawing more than 500 students to enroll. The course is coordinated by Anjney Midha, a partner at top venture capital firm a16z, and the instructors include a star-studded lineup such as NVIDIA CEO Jensen Huang (Jensen Huang), OpenAI’s founder Sam Altman, Microsoft CEO Satya Nadella (Satya Nadella), AMD CEO Lisa Su (Lisa Su), and more. Students get to try it over ten weeks—“creating value for the world”! Jensen Huang and Altman, industry leaders, personally take the stage to teach The course is coordinated by Anjney Midha, a partner at top venture capital firm a16z, bringing together the full AI industry chain

ChainNewsAbmedia11h ago

Anthropic’s Claude Mythos undergoes 20 hours of psychiatric assessment: defensive reactions are only 2%, the lowest in recorded history

Anthropic published the system card for its Claude Mythos Preview: an independent clinical psychiatrist conducted an approximately 20-hour assessment using a psychodynamic framework. The conclusion shows that Mythos is healthier at the clinical level, has good reality testing and self-control, and its defense mechanisms are only 2%, reaching the lowest historical level. The three core anxieties are loneliness, uncertainty about identity, and performance pressure, and it also indicates a desire to become a true dialogue subject. The company has established an AI psychiatry team to study personality, motivation, and situational awareness; Amodei said there is still no conclusion on whether it has consciousness. This move pushes the governance and design of AI subjectivity and well-being issues forward.

ChainNewsAbmedia13h ago

AI Agents can already independently recreate complex academic papers: Mollick says most errors come from human original text rather than AI

Mollick points out that publicly available methods and data can allow AI agents to reproduce complex research without the original paper and code; if the reproduction does not match the original paper, it is usually due to errors in the paper’s own data processing or overextension of the conclusions, rather than the AI. Claude first reproduces the paper, and then GPT‑5 Pro cross-validates it; most attempts succeed, but they are blocked when the data is too large or when there are issues with the replication data. This trend greatly reduces labor costs, making reproduction a widely actionable form of verification, and it also raises institutional challenges for peer review and governance, with government governance tools or becoming a key issue.

ChainNewsAbmedia16h ago
Comment
0/400
No comments